American Society of Clinical Oncology (ASCO) 2025 Annual Meeting

Each year, Rutgers Cancer Institute and RWJBarnabas Health participate in the American Society of Clinical Oncology's Annual Meeting. This participation includes presentations by our experts, hosting of a booth in the exhibit hall and a reception.

Through 45 accepted abstracts and presentations, the institutions will highlight innovative oncology research across a range of tumor types and specialties, including two oral sessions featuring a multisite randomized trial focused on psychosocial support for young adults with cancer, and new findings from a study evaluating pathologic complete response in HER2-positive breast cancer using clinicopathologic variables and the HER2DX pCR score. Learn more about the research presented at the 2025 ASCO Annual Meeting.


Videos


Event Photos (Click to Enlarge.)

Related Articles and Press

ASCO Booth at 2024 conference

RWJBarnabas Health and Rutgers Cancer Institute to Present Practice-Changing Research at 2025 ASCO Annual Meeting

Clinicians and scientists from RWJBarnabas Health and Rutgers Cancer Institute will share new findings and lead discussions at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting, showcasing advances from their cutting-edge cancer research program.


Learn more about past ASCO meetings →